Jadwiga Rogozińska-Szczepka

Learn More
Germline mutations in the BRCA1 or BRCA2 genes predispose their carriers to breast or/and ovary cancers during their lifetime. The most frequent mutations: 5382insC, 185delAG, C61G and 4153delA in BRCA1, and 6174delT and 9631delC in BRCA2 were studied in a group of 148 probands admitted for genetic counseling, using allele-specific amplification (ASA) PCR(More)
BACKGROUND Incidence of primary bilateral breast cancer (BC) is rare and does not exceed 5%. BRCA1/2 mutation carriers diagnosed with breast cancer have a strong life time risk of developing contralateral breast cancer (53% versus 2%). PATIENTS AND METHODS A group of 108 patients with bilateral breast cancer, who reported at our Cancer Centres from 2000(More)
INTRODUCTION Cancer-associated retinopathy (CAR) is a paraneoplastic neurological syndrome resulting in progressive loss of vision and clinical signs of retinal degeneration. It is associated with various types of cancer and is also considered to be an autoimmune disorder that involves cross-reaction between autoantibodies and retinal proteins. The aim of(More)
Germline mutations in BRCA1 and BRCA2 were analyzed in DNA isolated from white blood cells of patients with a family history of breast and ovarian cancers. We found one mutation in the BRCA1 gene — 300T/G missense mutation in exon 5 disrupting the zinc finger — already found in other families. In 5 families three different mutations were discovered in(More)
  • 1